# Filing Detail

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001214659-21-013618
Filing Date
2021-12-27
Accepted
2021-12-27 06:06:38
Documents
8

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | AMENDMENT NO. 4 | j1223210sc13da4.htm | SC 13D/A | 67151
2 | GRAPHIC | ex99_b1.jpg | GRAPHIC | 132316
3 | GRAPHIC | ex99_b2.jpg | GRAPHIC | 142052
4 | GRAPHIC | ex99_b3.jpg | GRAPHIC | 16327
5 | GRAPHIC | ex99_b4.jpg | GRAPHIC | 94301
6 | GRAPHIC | ex99_b5.jpg | GRAPHIC | 176838
7 | GRAPHIC | ex99_b6.jpg | GRAPHIC | 66874
8 | GRAPHIC | ex99_b7.jpg | GRAPHIC | 54535
| Complete submission text file | 0001214659-21-013618.txt |  | 1010250

Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Subject) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90395 | Film No.: 211518848
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11 SUMMIT LANE GREENVILLE DE 19807
Business Address
Grant Stuart M. (Filed by) CIK: 0001783415 (see all company filings)

Type: SC 13D/A